Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $383.66 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $118.47 | 5 | $0 (2023) |
| Alcon Vision LLC | $48.57 | 2 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $44.65 | 2 | $0 (2024) |
| Shire North American Group Inc | $43.53 | 2 | $0 (2019) |
| ABBVIE INC. | $24.77 | 1 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $24.58 | 1 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $23.88 | 1 | $0 (2018) |
| Oyster Point Pharma, Inc. | $20.47 | 1 | $0 (2023) |
| EYEVANCE PHARMACEUTICALS LLC | $19.36 | 1 | $0 (2022) |
| NovaBay Pharmaceuticals, Inc. | $15.38 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55.24 | 2 | SUN PHARMACEUTICAL INDUSTRIES INC. ($30.66) |
| 2023 | $72.63 | 3 | Novartis Pharmaceuticals Corporation ($27.39) |
| 2022 | $38.77 | 2 | Alcon Vision LLC ($19.41) |
| 2020 | $29.16 | 1 | Alcon Vision LLC ($29.16) |
| 2019 | $71.06 | 3 | Novartis Pharmaceuticals Corporation ($46.70) |
| 2018 | $44.96 | 2 | Aerie Pharmaceuticals, Inc. ($23.88) |
| 2017 | $71.84 | 4 | Novartis Pharmaceuticals Corporation ($23.30) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: Ophthalmology | ||||||
| 04/22/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Ophthalmology | ||||||
| 08/16/2023 | ABBVIE INC. | VUITY (Drug), LUMIGAN, ALPHAGAN P | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: EYE CARE | ||||||
| 08/10/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Ophthalmology | ||||||
| 07/06/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: DRY EYE | ||||||
| 09/01/2022 | EYEVANCE PHARMACEUTICALS LLC | Flarex (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: OPHTHALMIC | ||||||
| 06/28/2022 | Alcon Vision LLC | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Glaucoma | ||||||
| 02/04/2020 | Alcon Vision LLC | ILUX (Device) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Ophthalmology | ||||||
| 11/19/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/18/2019 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/07/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: OPTHALMICS | ||||||
| 11/29/2018 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/30/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Ophthalmology | ||||||
| 08/28/2017 | NovaBay Pharmaceuticals, Inc. | Avenova (Device) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: Ophthalmology | ||||||
| 07/07/2017 | Sun Pharmaceutical Industries Inc. | Bromsite (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Ophthalmology | ||||||
| 05/09/2017 | Novartis Pharmaceuticals Corporation | PAZEO (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/21/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: OPTHALMICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,465 | 1,573 | $201,730 | $110,653 |
| 2022 | 9 | 1,411 | 1,504 | $197,395 | $105,531 |
| 2021 | 9 | 1,271 | 1,330 | $173,305 | $97,185 |
| 2020 | 9 | 1,002 | 1,041 | $136,490 | $74,778 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 743 | 779 | $119,685 | $73,425 | 61.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 192 | 234 | $26,300 | $15,252 | 58.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 176 | 193 | $19,600 | $8,028 | 41.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 50 | 50 | $9,820 | $5,476 | 55.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 150 | 160 | $12,100 | $3,958 | 32.7% |
| 92134 | Imaging of retina | Office | 2023 | 53 | 55 | $4,225 | $1,635 | 38.7% |
| 92250 | Photography of the retina | Office | 2023 | 59 | 59 | $7,475 | $1,553 | 20.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $1,425 | $907.92 | 63.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 21 | 22 | $1,100 | $418.83 | 38.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 739 | 779 | $120,700 | $70,267 | 58.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 163 | 200 | $22,560 | $13,019 | 57.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 73 | 73 | $14,075 | $8,068 | 57.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 172 | 182 | $18,600 | $7,691 | 41.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 152 | 157 | $11,925 | $3,692 | 31.0% |
| 92134 | Imaging of retina | Office | 2022 | 50 | 51 | $3,875 | $1,371 | 35.4% |
| 92250 | Photography of the retina | Office | 2022 | 36 | 36 | $4,600 | $1,030 | 22.4% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 14 | 14 | $700.00 | $280.03 | 40.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 12 | 12 | $360.00 | $111.59 | 31.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 620 | 646 | $98,475 | $59,867 | 60.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 159 | 183 | $20,130 | $12,022 | 59.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 101 | 101 | $20,015 | $11,530 | 57.6% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 150 | 154 | $15,500 | $6,775 | 43.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 123 | 127 | $9,525 | $3,258 | 34.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 43 | 43 | $3,225 | $1,359 | 42.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 26 | 27 | $1,755 | $1,109 | 63.2% |
About Dr. Michael Piacentini, M.D
Dr. Michael Piacentini, M.D is a Ophthalmology healthcare provider based in Manchester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477547941.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Piacentini, M.D has received a total of $383.66 in payments from pharmaceutical and medical device companies, with $55.24 received in 2024. These payments were reported across 17 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($383.66).
As a Medicare-enrolled provider, Piacentini has provided services to 5,149 Medicare beneficiaries, totaling 5,448 services with total Medicare billing of $388,147. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Manchester, MA
- Active Since 09/09/2005
- Last Updated 05/17/2010
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1477547941
Products in Payments
- XIIDRA (Drug) $95.28
- TRAVATAN Z (Drug) $43.42
- Cequa (Drug) $30.66
- ILUX (Device) $29.16
- VUITY (Drug) $24.77
- MIEBO (Drug) $24.58
- Rhopressa (Drug) $23.88
- PAZEO (Drug) $23.30
- TYRVAYA (Drug) $20.47
- rocklatan (Drug) $19.41
- Flarex (Drug) $19.36
- Avenova (Device) $15.38
- Bromsite (Drug) $13.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Manchester
Ahad Fazelat, M.d, M.D
Ophthalmology — Payments: $8,451
Richard Fichman, M.d, M.D
Ophthalmology — Payments: $3,287
Stephanie Choi
Ophthalmology — Payments: $2,935
Dr. Steve Tu, D.o, D.O
Ophthalmology — Payments: $2,724
Marion Stoj, M.d, M.D
Ophthalmology — Payments: $1,929
Dr. Jason Hall, M.d, M.D
Ophthalmology — Payments: $1,743